Ronald Gust Selected Research

Ronald Gust Research Topics

Disease

38	Breast Neoplasms (Breast Cancer) 02/2022 - 08/2002
33	Neoplasms (Cancer) 07/2022 - 03/2004
15	Carcinoma (Carcinomatosis) 02/2022 - 02/2007
10	Leukemia 03/2021 - 03/2004
9	Lymphoma (Lymphomas) 10/2013 - 03/2004
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2021 - 11/2006
4	Colonic Neoplasms (Colon Cancer) 10/2011 - 04/2008
3	Necrosis 03/2011 - 04/2008
3	Prostatic Neoplasms (Prostate Cancer) 03/2007 - 12/2004
2	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2008
2	Neuroblastoma 01/2020 - 12/2019
2	Carcinogenesis 11/2019 - 12/2008
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2011 - 04/2008
1	Ovarian Neoplasms (Ovarian Cancer) 05/2020
1	Hemolysis 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Malignant Mesothelioma 12/2013
1	Insulin Resistance 11/2012
1	Diabetes Mellitus 11/2012
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2010
1	Alzheimer Disease (Alzheimer's Disease) 08/2010

Drug/Important Bio-Agent (IBA)

13	PlatinumIBA 07/2022 - 06/2004
10	LigandsIBA 01/2020 - 03/2004
9	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 01/2007
9	Pharmaceutical PreparationsIBA 04/2021 - 06/2004
6	Imatinib Mesylate (Gleevec)FDA Link 04/2021 - 11/2006
6	Biological ProductsIBA 07/2012 - 02/2007
6	Estrogen ReceptorsIBA 11/2011 - 08/2002
6	Hormones (Hormone)IBA 03/2009 - 04/2003
5	GoldIBA 07/2022 - 05/2007
5	Coordination ComplexesIBA 07/2022 - 03/2007
5	Estrogens (Estrogen)FDA Link 04/2020 - 06/2004
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 06/2004
5	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 04/2008 - 06/2004
4	IronIBA 12/2019 - 11/2009
4	IsoenzymesIBA 11/2019 - 10/2010
4	Cytostatic AgentsIBA 10/2010 - 01/2007
4	LuciferasesIBA 11/2005 - 08/2002
3	CobaltIBA 02/2022 - 03/2004
3	Alkynes (Acetylenes)IBA 02/2022 - 03/2004
3	Dendrimers (Dendrons)IBA 11/2020 - 04/2008
3	Peptides (Polypeptides)IBA 10/2020 - 07/2010
3	PPAR gammaIBA 01/2020 - 11/2012
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2013 - 10/2010
3	Fluorouracil (Carac)FDA LinkGeneric 10/2012 - 04/2008
3	Estrogen Receptor alphaIBA 07/2010 - 02/2004
3	DiaminesIBA 06/2006 - 06/2004
3	Estradiol (Delestrogen)FDA LinkGeneric 10/2003 - 08/2002
2	Arachidonic Acid (Vitamin F)IBA 02/2022 - 10/2010
2	Drug CarriersIBA 11/2020 - 05/2011
2	EstersIBA 01/2020 - 11/2006
2	Telmisartan (Micardis)FDA Link 01/2020 - 05/2008
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 11/2005
2	propynyl benzoateIBA 12/2013 - 04/2005
2	AcidsIBA 07/2011 - 11/2006
2	Melphalan (Alkeran)FDA LinkGeneric 05/2011 - 10/2010
2	Bendamustine Hydrochloride FDA Link 05/2011 - 10/2010
2	MetalsIBA 04/2011 - 03/2007
2	RhodiumIBA 03/2011 - 02/2009
2	Propidium (Propidium Iodide)IBA 03/2011 - 07/2010
2	Prostaglandins EIBA 11/2010 - 10/2010
2	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 02/2009 - 05/2006
2	Transforming Growth Factor beta (TGF-beta)IBA 12/2008 - 03/2006
2	NucleosidesIBA 01/2008 - 04/2007
2	Carboplatin (JM8)FDA LinkGeneric 03/2007 - 01/2007
2	ethyleneIBA 06/2004 - 06/2004
1	EnzymesIBA 02/2022
1	Cholecystokinin B ReceptorIBA 10/2020
1	minigastrinIBA 10/2020
1	Angiotensin II Type 1 Receptor BlockersIBA 06/2020
1	Auranofin (Ridaura)FDA Link 05/2020
1	Selective Estrogen Receptor Modulators (SERM)IBA 04/2020
1	Aromatase InhibitorsIBA 04/2020
1	indoleIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	CarbenoxoloneIBA 01/2020
1	MicellesIBA 01/2020
1	LipidsIBA 12/2019
1	FluorineIBA 01/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2013
1	Methanol (Carbinol)IBA 12/2013
1	Hydroxyl RadicalIBA 10/2013
1	ScopoletinIBA 08/2012
1	SilverIBA 12/2011
1	Nitric Oxide DonorsIBA 08/2011
1	licofeloneIBA 08/2011
1	Dasatinib (BMS 354825)FDA Link 07/2011
1	salophenIBA 04/2011
1	ManganeseIBA 04/2011
1	Schiff Bases (Schiff Base)IBA 04/2011
1	ProstaglandinsIBA 11/2010
1	Iron(III)-salopheneIBA 11/2010
1	benzamideIBA 10/2010
1	Dinoprostone (PGE2)FDA Link 10/2010
1	Amino Acids FDA Link 08/2010
1	Peptide Hydrolases (Proteases)FDA Link 07/2010
1	Annexin A5IBA 07/2010

Therapy/Procedure

11	Therapeutics 04/2021 - 06/2004
2	Drug Therapy (Chemotherapy) 07/2022 - 03/2007